The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma

Domenica Lorusso, Giovanni Scambia, Nicoletta Colombo, Amit M. Oza, Carol Aghajanian, Ana Oaknin, Andrew Dean, Johanne I. Weberpals, Andrew R. Clamp, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O'Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M. Swisher, Juliette MeunierTerri Cameron, Lara Maloney, Sandra Goble, Josh Bedel, Jonathan A. Ledermann, Robert L. Coleman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences